Forever Young Pharmacy
Retatrutide
Finnrick tested 8 samples of Retatrutide (GLP-1, GIP, and GCGR antagonist) from Forever Young Pharmacy between 17 Dec 2024 and 31 Mar 2025. Tests score average over 0, no score below 0, and at least 6 tests warrant a confident Finnrick Rating of E (Bad).
Finnrick Rating™
Forever Young Pharmacy
Retatrutide
Tested 8 Samples
Last test 31 Mar 2025
Take Action
Mail in a Sample
We test your peptides for free: mail in a sample you have (US only), or request us to test a vendor.
Retatrutide is also available from top-rated vendors:
All Retatrutide tests from Forever Young Pharmacy
Samples are tested in commercial labs
Tests Count
8
Scores
AVGMINMAX
Last
31 Mar 2025
First
17 Dec 2024
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Test Score | Label | Batch | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 31 Mar 2025 | 10mg | (no batch claim) | 11.058mg | +10.6% | 98.29% | (no batch ID) | White Label / Green Cap | Lab C | Public | |
| 28 Mar 2025 | 20mg | (no batch claim) | 22.280mg | +11.4% | 98.78% | (no batch ID) | White Label / Pink Cap | Lab C | Public | |
| 28 Mar 2025 | 10mg | (no batch claim) | 11.793mg | +17.9% | 89.66% | (no batch ID) | White Label / Clear Cap | Lab C | Public | |
| 19 Feb 2025 | 10mg | ⚠️ Sample does not contain Retatrutide | 224992 | White Label / Blue Cap | Lab B | Finnrick | ||||
| 14 Feb 2025 | 10mg | ⚠️ Sample does not contain Retatrutide | 224992 | White Label / Blue Cap | Lab A | Finnrick | ||||
| 13 Feb 2025 | 10mg | ⚠️ Sample does not contain Retatrutide | 224992 | White Label / Blue Cap | Lab C | Finnrick | ||||
| 13 Feb 2025 | 10mg | ⚠️ Sample does not contain Retatrutide | 224992 | White Label / Blue Cap | Lab C | Finnrick | ||||
| 17 Dec 2024 | 12mg | (no batch claim) | 14.230mg | +18.6% | 99.86% | 22449 | White Label / Light Green Cap | Lab A | Finnrick | |
Corrections
- 6 Apr 2025
- Lab A test 14 Feb 2025: updated compound identification, removed purity and quantity values. Error in analysis by lab, compound was incorrectly identified as Retatrutide. Lab issued an updated test certificate.